retatrutide safety profile clinical trials The FDA has issued warning letters to multiple companies marketing compounded Retatrutide for Women: Safety, Results

Pharmaceutical companies originally built them for type 2 diabetes

Hypersensitivity reactions (rash, pruritus, urticaria) Alongside gastrointestinal issues, another category of side effects that has been observed with retatrutide in the clinical development programme is hypersensitivity reactions

The weight loss came with broad metabolic improvements

95% CI, 0.54-1.11) did not reach statistical significance

This represents a meaningful advancement in how post-market drug safety can be monitored and it is exactly the kind of AI-supported insight that may become more common as these tools improve

To experience a healthier gut and improved digestion during GLP-1 use, reach for Gut Responses cutting-edge GLP-1 Support formula